Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for RIFAMPIN
- Drug-durg Interaction of Leritrelvir(RAY1216) With Midazolam, Omeprazole, Rosuvastatin, Verapamil, and Rifampin
- Evaluation of the Effect of Rifampin and Rabeprazole on the Pharmacokinetics of Camlipixant
- A Study to Assess Pharmacokinetics (PK) of Brensocatib Alone and With Multiple Doses of Rifampin or Esomeprozole in Healthy Participants
- Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Hidradenitis Suppurativa Patients
- Short-course Regimens for the Treatment of Pulmonary Tuberculosis
- HMPL-523 CYP3A/P-gp Inhibitor and CYP Inducer Study
- A Study to Evaluate the Relative Bioavailability of STI-1558 and the Effect of Itraconazole and Rifampin on the Pharmacokinetics of STI-1558
- Evaluation of the Effects of Omeprazole and Rifampin on the Pharmacokinetics of VX-548 in Healthy Participants
- HMPL-689 Drug Interaction Study With CYP3A Inhibitor/CYP2C9 Inhibitor/CYP3A Inducer/PPI
- Drug-drug Interaction Study of XZP-3621 Tablet
- A Study to Evaluate the Drug-drug Interaction Effect of Rifampin on the Pharmacokinetics of AMG 510 in Healthy Participants
- Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible TB
- Effects of Rifampicin and Probenecid On The Pharmacokinetic Profile Of Rongliflozin In Healthy Subjects
- Sitafloxacin-containing Regimens for Shortening Tuberculosis Treatment
- Efficacy Of Doxycycline & Versus Rifampin In Treatment Of Rhinoscleroma
- A Study to Assess the Drug Levels of CC-92480 After Coadministration With Rifampin and Itraconazole, and the Drug Levels of Digoxin and Rosuvastatin After Coadministration With CC-92480 in Healthy Participants
- Drug-drug Interaction Study of SPH3127
- A Study of AB-106 in Chinese Healthy Adult Men Evaluated the Effects of Itraconazole and Rifampicin on AB-106 PK
- A Study of Effects of Itraconazole and Rifampin on Selpercatinib (LY3527723) in Healthy Participants
- DDI Study of Orelabrutinib
- RiLuzole to Reduce Atrial FIbrillatiON A Prospective, Double-Blind, Randomized, Placebo-Controlled Study Using Holter Monitoring
- PK Study to Assess Drug-drug Interaction Between Sitravatinib and a P-gp Inducer and an Inhibitor.
- Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB
- Study of the Effects of Itraconazole and Rifampin on LOXO-305 in Healthy Participants
- A Study of Soticlestat and Rifampin in Healthy Adults
- A Study to Evaluate Drug-Drug Interaction of Larotinib With Itraconazole and Rifampin in Healthy Adult Participants
- Short-course Rifamycin-based Regimens for Latent Tuberculosis in Patients With End-stage Kidney Disease
- Testing New Strategies for Patients Hospitalised With HIV-associated Disseminated Tuberculosis
- Drug Interaction Study of ALXN2050 With Fluconazole and Rifampin in Healthy Adult Participants
- Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)
- Hypertonic Saline for MAC
- A Study to Evaluate the One-way Interaction of Calcium Carbonate, Omeprazole, or Rifampin on ACP-196
- Drug-drug Interaction Study of CTP-543 and Rifampin in Healthy Adult Subjects
- Study to Evaluate the Effects of Itraconazole and Rifampin on the Pharmacokinetics of ASC40 in Healthy Subjects
- Impact of Rifabutin on the Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor
- DTG Plus 3TC for Prophylaxis of Mother-to-child Transmission of HIV Infection in Pregnant Women
- Rifampicin at High Dose for Difficult-to-Treat Tuberculosis
- A New Treatment for Primary Smear-positive Pulmonary Tuberculosis With Interleukin-2
- Drug Exposure and Safety of a Shorter Tuberculosis Treatment Based on High-Dose Rifampicin and Pyrazinamide
- Drug-Drug Interaction of SHR1459 With a Strong CYP3A Index Inducer (Rifampicin)
- Drug to Drug Interaction Study of KBP-5074 in Healthy Subjects
- IMP4297 DDI (Drug-Drug Interaction)Trial in Healthy Male Volunteers
- A Rifampin Effect Study of SHR2554 on Healthy Chinese Adult Subjects
- A Study to Assess the Effect of Food Intake and Drug-drug Interactions of E7090 When Co-administered With Rabeprazole or Rifampin in Healthy Participants
- Evaluation of Effect of Rifampin on the Pharmacokinetics of Vonoprazan in Healthy Participants
- Fruquintinib CYP3A Inhibitor and Inducer Study
- A Two-part Study to Characterize Drug-Drug Interaction Effects on Steady-State Pharmacokinetics of Oral Tazemetostat
- Surufatinib DDI With a PPI and a CYP3A Inducer
- Rifampin and the Contraceptive Implant
- Atovaquone for Treatment of COVID-19
- A Study to Assess the Effects of Itraconazole and Rifampin on Lazertinib in Healthy Adult Participants
- A Study of Steady-state Rifampin on the Single-dose of Erdafitinib Tablets in Healthy Adult Participants
- The Effect of Tesetaxel on the QTc Interval and the Effect of Food, Itraconazole, and Rifampin on Tesetaxel Pharmacokinetics in Patients With Advanced Solid Tumors
- Study to Evaluate the Effect of Rifampin on the Drug Levels in Blood and Safety of BMS-986235 in Healthy Participants
- Annovera™ Drug-Drug Interaction Study
- A Study to Evaluate Potential Cytochrome P450 and Transporter Protein Interactions With CC-99677
- Study to Evaluate the Effect of Repeat-Dose Rifampin on the Pharmacokinetics (PK) of PF-06651600
- Efficacy and Safety of Isoniazid, Rifampicin and Moxifloxacin for the Intensive Phase of Initial Therapy of PTB
- A Drug-Drug Interaction Study of CYP3A4 Inhibition and Pan-CYP Induction on APX001
- A Study to Assess CYP3A4 Modulator, Oral Contraceptive, and pH Modifier Drug Interactions for ABI-H2158 in Healthy Adults
- A Study to Evaluate the Effect of Single-Dose Intravenous Rifampin as a Prototypic Inhibitor of Organic Anion Transporting Polypeptide (OATP) 1B1 and OATP1B3 on the Single-Dose Pharmacokinetics (PK) of Oral TAK-906 in Healthy Adult Participants
- A Study in Healthy Subjects to Assess the Pharmacokinetics of Savolitinib When Administered Alone and in Combination With Rifampicin
- Risk of SDRs Under 3HP and 1HP Regimen for LTBI
- Drug-Drug Interaction Between Rifampin and Fluvastatin
- Adjunctive Linezolid for the Treatment of Tuberculous Meningitis
- The Drug Interaction Between Albuvirtide (ABT) and Rifampin（RIF） in Healthy Adult Subjects
- Study to Investigate the Effect of Rifampin and Itraconazole on the Action of Pamiparib in Participants With Cancer
- Study to Evaluate the Effect of Multiple Doses of Itraconazole and Rifampin on the Single-Dose Pharmacokinetics of Mitapivat Sulfate (AG-348) in Healthy Adult Participants
- 2R2: Higher Dose Rifampin for 2 Months vs Standard Dose Rifampin for Latent TB.
- Effect of Rifampin and Efavirenz on the Pharmacokinetics of Fedratinib in Healthy Adult Subjects
- Effect of Multiple Doses of Modafinil on the Pharmacokinetics of Single Dose Lorlatinib in Healthy Participants
- Azacytidine During Anti-tuberculosis Therapy
- A Study to Evaluate Drug-Drug Interaction of TAK-788 With Itraconazole and Rifampin in Healthy Adult Participants
- Drug-Drug Interaction Study of Vadadustat With Cyclosporine, Probenecid and Rifampin
- Optimizing Antituberculosis Therapy in Adults With Tuberculous Meningitis
- A Study Evaluating Drug-Drug Interaction (DDI) Between HSK3486 Injectable Emulsion and Rifampin Capsules
- Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy Subjects
- Efficacy, Safety and Pharmacokinetics of DTG With RIF
- A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib
- An Investigational Study of Experimental Medication BMS-986278 Given With the Antibiotic Rifampin in Healthy Participants
- Pharmacokinetics Study to Evaluate Drug-Drug Interactions and Safety of Elpida® in Co-Administration With Other Drugs
- Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population
- Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease
- Drug Interaction Study Evaluating the Effect of Rifampin on PK and Safety of PF 04965842.
- Drug-drug Interaction Study of Ozanimod With Inhibitor or Inducer of CYP2C8 and/or CYP3A
- Colistin-rifampin Combination and Colistin Monotherapy in Extensively Drug-resistant Acinetobacter Baumannii
- NGS-Guided(G) Regimens(R) of Anti-tuberculosis(A) Drugs for the Control(C) and Eradication(E) of MDR-TB
- Immediate Versus Delayed Insertion of Implanon in Postpartum Adolescents
- An Investigational Study to Evaluate the Effect of Rifampin on the Singe Dose of Experimental Medication BMS-986224 in Healthy Participants
- Pilot Clinical Trial of PRS TB Regimen I - Phase II
- A Study to Evaluate the Effects of Rifampin on Pharmacokinetics (PK) of Pevonedistat in Participants With Advanced Solid Tumors
- Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI
- Same-Day Treatment With Genvoya vs. EFV/TDF/3TC
- The Antibiotic Rifampin to Reduce High Levels of Blood and Urine Calcium in IIH
- Tedizolid Prolonged Treatment for Prosthetic Joint Infections
- A Study to Evaluate the Effect of 2 Drugs on the Pharmacokinetics of BMS-986205 in Healthy Subjects
- Study Evaluating the Effects of Food, Cytochrome P450 Inhibition and Induction on the Pharmacokinetics of CC-122
- Comparison Between Rifampicin and Gemifloxacin and Ciprofloxacin in Treatment of Rhinoscleroma
- Pharmacokinetics of Midazolam, Dabigatran, Pitavastatin, Atorvastatin, and Rosuvastatin in Participants With Renal Insufficiency in the Presence and Absence of Rifampin (MK-0000-386)
- This Study Tests the Effect of Certain Medicines on the Transport of Other Medicines in the Body of Healthy Men
- Phase 1 Study to Investigate Effect of Rifampin and Itraconazole on the Pharmacokinetics of BGB-3111 in Healthy Subjects
- Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria
- Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects
- Crossover Drug-Drug Interaction Study to Determine Effects of Cytochrome P450 3A on Exposure to Mifepristone and Its Metabolites
- CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections
- Drug-drug Interaction Study Between EDP-305, Intraconazole and Rifampin in Healthy Volunteers
- Single-dose Study of [14C]Lorlatinib (PF-06463922) Metabolism In Healthy Male Volunteers
- Early Bactericidal Activity of Rifampin + Meropenem + Amoxicillin/Clavulanate in Adults With Pulmonary TB
- S. Aureus Decolonization in HPN Patients.
- Drug-drug Interaction (DDI) With a P-gp Inhibitor, Organic Anion Transporting Polypeptide OATP-inhibitor, Food Effect
- Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings
- A Study to Evaluate the Effect of Itraconazole and Rifampin on the Pharmacokinetics of Talazoparib in Patients With Advanced Solid Tumors
- Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics
- Efficacy and Tolerability of Delamanid, Linezolid, Pyrazinamide and Levofloxacin
- A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics of BMS-986177 in Healthy Subjects
- Optimizing Treatment to Improve TBM Outcomes in Children
- A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects
- Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis
- Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Healthy Han Chinese, Korean, Japanese, and Caucasian Participants and the Effects of Rifampin on the Pharmacokinetics of Intranasally Administered Esketamine
- Effect of Rifampicin on the Pharmacokinetics of Apatinib
- Study to Evaluate the Effect of Cytochrome P450 (CYP) 3A Inhibition and Induction on the Pharmacokinetics of CC-220 in Healthy Subjects
- Study to Assess Pharmacokinetic Drug-Drug Interaction Between Avatrombopag When Co-Administered With Fluconazole, Itraconazole, or Rifampin in Healthy Subjects
- Perioperative Antibiotic Therapy to Prevent Cardiac Implantable Electronic Device Infections.
- Drug-Interaction Study to Evaluate the Effect of Rifampin, a Potent CYP3A4 Inducer, on the Systemic Exposure of Pacritinib in Healthy Subjects
- A Study To Evaluate The Effect Of Rifampin On Pharmacokinetics Of PF-06463922 In Healthy Volunteers
- A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis
- A Drug Interaction Study in Healthy Participants to Assess the Effect of Rifampin on the Pharmacokinetics of JNJ-42847922
- Clindamycin-rifampin Drug Interaction in the Treatment of Bone and Joint Infections
- A Study to Investigate the Effect of Itraconazole and Rifampin on Pharmacokinetics (PK) of Vemurafenib at Steady State
- Evaluating Celecoxib Activity in Mycobacterium Tuberculosis: A Whole Blood Bactericidal Activity Study in Healthy Volunteers
- Evaluating the Safety, Tolerability, and Pharmacokinetics of Bedaquiline and Delamanid, Alone and in Combination, For Drug-Resistant Pulmonary Tuberculosis
- Phenotypic Drug Probes as Predictors of Drug-drug Interactions With Tacrolimus
- Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis
- Fermented Soybean Supplementation Among Active Pulmonary Tuberculosis Patients With Standard Therapy in Indonesia
- Epidemiology and Treatment of Small-colony Variant Staphylococcus Aureus in Cystic Fibrosis
- Impact of Two Genetic Variants of OATP1B3 or MRP2 or Rifampin on Systemic Disposition and Biological Efficacy of CCK-8
- A Drug-Drug Interaction Study of N91115 +/- Rifampin in Healthy Adult Subjects
- PK Study of Anti-TB Drugs
- Understanding The Effect Of A Strong CYP3A4 Inducer On Glasdegib Pharmacokinetics
- Effect of Rifampin (RIF) on the Pharmacokinetics (PK) of Oral Cabotegravir (CAB) in Healthy Subjects
- TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens
- Effects of Rifampin on the Pharmacokinetics of Ataluren
- Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Faropenem Plus Amoxicillin/Clavulanic Acid in Healthy Volunteers
- Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Rifampicin in Healthy Volunteers
- Trial of Faropenem and Cefadroxil (in Combination With Amoxicillin/Clavulanic Acid and Standard TB Drugs) in Patients With Pulmonary Tuberculosis: Measurement of Early Bactericidal Activity and Effects on Novel Biomarkers
- Improving Treatment of Nontuberculous Mycobacterial Infection in Cystic Fibrosis
- NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in Tuberculosis
- Immunologic Effects of HCV Therapy With HARVONI in HCV Genotype 1 Chronically Mono-infected Active and Former IDUs
- The Effects of PXR Activation on Hepatic Fat Content
- Evaluate Effects of Multiple Doses of Rifampin and Clarithromycin on the Single Dose Pharmacokinetics of Deflazacort
- Drug-Drug Interaction Study in Healthy Adult Volunteers
- Raltegravir Versus Efavirenz in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis
- Assessing PA-824 for Tuberculosis (the APT Trial)
- A Study of LY2835219 in Healthy Participants
- COPANLISIB (BAY80-6946) Drug-drug Interaction and Cardiovascular Safety Study in Advanced Solid Tumor and Non-Hodgkin's Lymphoma Patients
- Rapid Detection of Rifampin and Isoniazid Resistance by PCR Before Tuberculosis (TB) Treatment Initiation
- A Pharmacokinetic Study to Assess the Influence of P-glycoprotein Inhibition and Simultaneous CYP3A4 and P-glycoprotein Induction on E7080 Pharmacokinetics Following Single Dose Oral Administration of 24 mg E7080 to Healthy Volunteers
- The Effect of Rifampin on the Metabolism of Istradefylline in Healthy Volunteers.
- A Study to Evaluate How a Drug That Alters Liver Enzymes (Rifampin) Affects the Metabolism of Enzalutamide in Men
- The Effects of Rifampin on the Pharmacokinetics of Rosuvastatin
- Patients Response to Early Switch To Oral:Osteomyelitis Study
- Influence of Rifampin Co-Administration on the Pharmacokinetic Profile of Daptomycin
- A 2-Part Study to Assess Potential Metabolism-Based Drug-Drug Interactions of E2006 When Coadministered With Itraconazole, Rifampin, Midazolam, or Bupropion
- A 3-Part, Open-Label, Drug-Drug Interaction Study of Concomitant Administration of E2609 With Itraconazole, Rifampin, Digoxin, or Donepezil
- Phase II Investigation of Antimycobacterial Therapy on Progressive, Pulmonary Sarcoidosis
- CYP3A4 Induction and Mineral Homeostasis
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- A Study to Assess the Effect of Rifampin on the Metabolism of ABT-199
- A Pharmacokinetics (PK) Study of the Effects Rabeprazole and Rifampin on Dabrafenib in Subjects With BRAF V600 Mutation Positive Tumors
- A Study To Investigate The Drug-Drug Interaction Potential Of Rifampin OnThe Investigational Agent Palbociclib (PD-0332991)
- Phase 1 Study in Healthy Subjects to Evaluate the Effect of Rifampin on the Pharmacokinetics of IPI-145
- Novel Therapeutics in Posttraumatic Stress Disorder (PTSD): A Randomized Clinical Trial of Mifepristone
- A Study of the Effect of Multiple Doses of Rifampin on the Single Dose Pharmacokinetics of RO5424802
- A Pilot Study for Pharmacokinetic Parameter of Colchicine in Patient Taking Rifampin
- A Study of Evacetrapib and Rifampin in Healthy Participants
- Safety, Tolerability and Pharmacokinetic (PK) of Concomitant Esomeprazole and Rifampin, and QT Study on Single and Multiple-doses of Alisertib
- A Drug Interaction Study of GDC-0032 Co-administered With Rifampin or Itraconazole in Healthy Volunteers
- Efficacy and Safety of Concomitant Use of Nevirapine and Rifampicin With HIV-TB
- A Phase 1 Study to Examine the Drug-Drug Interaction of Ciprofloxacin, Itraconazole, and Rifampin on the Combination of Lumacaftor With Ivacaftor in Healthy Adult Subjects
- A Pharmacokinetics (PK) Study to Investigate the Effect of Rifampin on PK of Vemurafenib (Zelboraf)
- A Study to Assess the Effect of Rifampin on the Pharmacokinetics of PCI-32765 in Healthy Participants
- Efficacy and Safety Study of Antibiotic Treatment to Treat Hip Prosthetic Joint Infection
- Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection
- Novel Therapeutics in Posttraumatic Stress Disorder (PTSD): A Randomized Clinical Trial of Mifepristone
- Pharmacokinetics (PK) of Antistaphylococcal Antibiotics in Infants (NICHD-2012-02-Staph Trio)
- Improving Tolerance of Treatment of Pulmonary MAC Infections
- Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir Given With Rifampin
- Pharmacokinetics of Tasimelteon Alone and in Combination With a CYP3A4 Inhibitor, Ketoconazole, or a CYP3A4 Inducer, Rifampin.
- Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)
- Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIV
- A Study to Evaluate the Efficacy and Safety of TMC207 in Patients With Pulmonary Infection With Multi-drug Resistant Mycobacterium Tuberculosis
- Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)
- Colistin and Rifampicin for MDR-Acinetobacter
- Buprenorphine Disposition and CYP3A
- Evaluating the Safety and Drug Interaction of PA-824, an Investigational Tuberculosis Medication, Together With Efavirenz, Ritonavir-Boosted Lopinavir, or Rifampin
- A Drug-Drug Interaction Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Apremilast
- Study in Healthy Volunteers to Investigate the Effects of Rifampin on the Pharmacokinetics of NKTR-118
- Treatment of Methicillin-sensitive Staphylococcus Aureus (MSSA)
- Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary Tuberculosis
- Pharmacokinetics Study of Oral IXAZOMIB in Participants With Advanced Nonhematologic Malignancies or Lymphoma
- Pharmacogenetics of Warfarin Induction and Inhibition
- Safety and Pharmacokinetics of Single and Multiple Dose Rifampin in Infants
- Randomized Controlled Trial of Standard Versus Systemic Decolonization Therapy for the Eradication of Methicillin-resistant Staphylococcus Aureus (MRSA) Colonization
- Trial of High-Dose Rifampin in Patients With TB
- Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors
- Comparing Two Preventive Regimens for Latent Tuberculosis Infection (LTBI)
- A Study to Evaluate the Effects of Rifampin on Single-Dose Pharmacokinetics of Canagliflozin in Healthy Volunteers
- Reintroduction Regimens After Hepatitis During Anti-tuberculosis Treatment
- A Phase 1 Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Tivozanib in Healthy Subjects
- Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)
- TMC207 +/- Rifabutin/Rifampin
- Influence of Rifampin on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer
- Effect of Rifampin on the Pharmacokinetics of BAY73-4506
- Colistin Plus Rifampicin in MDR P. Aeruginosa and A. Baumanii
- Study of Rifampicin in Multiple System Atrophy
- A Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies
- Dosing, Safety and Pharmacokinetic Profile of Rifabutin in Children Receiving Concomitant Treatment With Kaletra
- Effect Of Rifampin On Pharmacokinetics Of Sitaxsentan
- Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines
- Phase 1, Open Label, Two Arm, Fixed Sequence Study to Evaluate the Effect of Rifampin and Rifabutin on GSK1349572 Pharmacokinetics in Healthy Male and Female Volunteers
- Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced Solid Tumors
- Estimate The Effect Of Repeat-Dose Rifampin On The Pharmacokinetics Of CP-690,550 In Healthy Volunteers
- Estimation Of Effect Of Rifampin On Pharmacokinetics Of Crizotinib In Healthy Volunteers
- Daptomycin With Rifampin for Treatment of Staphylococcal Prosthetic Joint Infection
- A Study to Assess the Effect of Rifampin on the Metabolism of Navitoclax
- Rifampin Drug-Drug Interaction Study With Lurasidone HCl
- Trial of Antimycobacterial Therapy in Sarcoidosis
- Effect of Rifampin on the Pharmacokinetics of Dapagliflozin in Healthy Subjects
- Trial Comparing Efficacy of Treatments for Hidradenitis Suppurativa
- Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients
- High Dose Rifapentine Pharmacokinetics, Tolerability and Safety Dosage Rifapentine for Treatment of Tuberculosis
- Comparison of Concentration-time Course of Plasma and Intracellular Raltegravir in Healthy Volunteers
- Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35)
- Study of VX-770 and Rifampin in Healthy Male Subjects
- Drug-Drug Interaction Study With Rifampin
- Validation Study of Multiple Probe Compounds for Drug Interaction Evaluation
- Interplay Between Organic Anion Transporting Polypeptide (OATP) Transporters Transporters and CYP2C9 in Glyburide Pharmacokinetics (PK)
- Randomized Clinical Trial Comparing 4RIF vs. 9INH for LTBI Treatment-effectiveness
- A Study to Evaluate the Effects of Combining Cabazitaxel With Cisplatin Given Every 3 Weeks in Patients With Advanced Solid Cancer
- Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications
- Study Evaluating The Potential Effect Of Rifampin On The Pharmacokinetics Of Neratinib
- Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary Tuberculosis
- Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis
- Study of Daily Rifapentine for Pulmonary Tuberculosis
- Efavirenz (EFV) in HIV-Infected and HIV/Tuberculosis (TB) Coinfected Children
- Drug Interaction Study of Rifampin and Warfarin in Healthy Volunteers.
- Pharmacokinetic Interaction Study to Assess the Effect of Repeat Doses of Rifampin on Mirabegron (YM178) in Healthy Volunteers
- An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin
- Active Screening of Latent TB Infection, Treatment and Long Term Follow-up in Prison
- TMC435350-TiDP16-C105: Phase I, 3-way Crossover, Drug-drug Interaction Between TMC435350 and Rifampin After Multiple Dosing.
- Rifapentine Plus Moxifloxacin for Treatment of Pulmonary Tuberculosis
- Effect of Rifampin on Bosutinib When Both Are Given to Healthy People
- A Pilot Study of Inflammatory Markers in Alzheimer's Disease
- Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis
- TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
- Ranolazine Versus Placebo Effects on Exercise Tolerance in Patients With Heart Disease and Peripheral Arterial Disease
- Sulforaphane as an Antagonist to Human PXR-mediated Drug-drug Interactions
- Use of Azithromycin and Rifabutin Administered 3 Times Weekly for the Treatment of M. Avium Complex (MAC) Lung Disease
- Use of Clarithromycin and Rifabutin for the Treatment of M. Avium Complex (MAC) Lung Disease
- A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
- Controlled Trial: 5-day Course of Rifampin Versus Doxycycline for the Treatment of Mild to Moderate Scrub Typhus
- Investigation of the Effect of N Acetylcysteine Against Anti-Tuberculosis Drugs Induced Liver Toxicity
- A Study of the Interaction of Rifampin and Vinflunine in Subjects With Advanced Cancer
- TMC207-C202: Study to Evaluate Bactericidal Activity of Multiple Oral Doses of TMC207 in Subjects With Sputum-Smear Positive Tuberculosis
- A Study to Determine the Best Dose of Antivirals in Patients With Both TB and HIV
- Prophylaxis of Fungal Invasive Infections in Leukemia
- Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin
- Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy
- Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Tuberculosis
- Rifampin Combination Therapy Versus Monotherapy in Early Staphylococcal Infections After Total Hip and Knee Arthroplasty
- Effects of Rifampin on the Pharmacokinetics of Nilotinib in Healthy Subjects
- The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin
- A Study in Healthy Subjects to Assess How Dosing of Rifampin Affects What the Body Does to a Dose of GW679769 (Casopitant).
- A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With Anergy
- Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis
- Short-Course Isoniazid and Rifampin Compared With Isoniazid for Latent Tuberculosis Infection
- Study to Determine the Impact of Multiple Doses of Rifampin on Single-dose Pharmacokinetics of HCV-796
- Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria
- A Randomized Trial of DOTS Versus Enhanced DOTS for Community Control of Tuberculosis
- Vancomycin vs. Vancomycin Plus Gentamycin in Treatment of MRSA Infection
- Prediction of Drug Interactions With CYP2C9 Substrates
- Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer
- Efficacy of Metronidazole Versus Metronidazole and Rifampin in CDAD Treatment
- Rifampin Versus Isoniazid for the Treatment of Latent Tuberculosis Infection in Children (P4v9)
- TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment
- TBTC Study 28: Moxifloxacin Versus Isoniazid for TB Treatment
- TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment
- Tuberculosis Treatment Shortening Trial
- Treatment of Latent TB Infection for Jailed Persons
- Clinical Trial of Rifampin and Azithromycin for the Treatment of River Blindness
- Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in Haiti
- Caspofungin to Prevent Candidiasis in Adults in Hospital Intensive Care Units
- Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected Adults
- Moxifloxacin As Part of a Multi-Drug Regimen For Tuberculosis
- Tuberculosis Prevention for HIV Infected Adults
- Antibiotic Treatment Trial Directed Against Chlamydia Pneumonia in Multiple Sclerosis
- TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or Intolerance
- TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis
- A Randomized, Double-Blinded, Placebo-Controlled, Phase II Inhaled Interferon Gamma-1b and Antimycobacterials to Treat Pulmonary Mycobacterium Avium Complex Infections
- Phase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium Avium Complex Pulmonary Disease
- A Six-Month Safety and Antiviral Study in HIV-1 Seropositive, AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cells/mm3 to Evaluate MK-639 Alone Versus Zidovudine (AZT) and 3TC Versus the Combination of MK-639 With AZT/3TC
- The Treatment of Tuberculosis in HIV-Infected Patients
- Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis
- A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDR
- A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.
- Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
- Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
Clinical trials list
click for details